Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
Kazuhide Tsuji, T Hamada, Akiko Uenaka, et al.
Cancer Immunology Immunotherapy (2008) Vol. 57, Iss. 10, pp. 1429-1437
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1082
Therapeutic cancer vaccines
Cornelis J.M. Melief, Thorbald van Hall, Ramon Arens, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3401-3412
Open Access | Times Cited: 1038
Synthetic Nanoparticles for Vaccines and Immunotherapy
Darrell J. Irvine, Melissa C. Hanson, Kavya Rakhra, et al.
Chemical Reviews (2015) Vol. 115, Iss. 19, pp. 11109-11146
Open Access | Times Cited: 696
Engineering synthetic vaccines using cues from natural immunity
Darrell J. Irvine, Melody A. Swartz, Gregory L. Szeto
Nature Materials (2013) Vol. 12, Iss. 11, pp. 978-990
Open Access | Times Cited: 539
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
Jianda Yuan, Sacha Gnjatic, Hao Li, et al.
Proceedings of the National Academy of Sciences (2008) Vol. 105, Iss. 51, pp. 20410-20415
Open Access | Times Cited: 344
Current advances in self-assembled nanogel delivery systems for immunotherapy
Yoshiro Tahara, Kazunari Akiyoshi
Advanced Drug Delivery Reviews (2015) Vol. 95, pp. 65-76
Closed Access | Times Cited: 163
Nanogels as target drug delivery systems in cancer therapy: A review of the last decade
Anthony A. Attama, Petra O. Nnamani, Ozioma B. Onokala, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 54
Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma
Yanhong Chu, Lingyu Qian, Yaohua Ke, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Recent Trends in Biosensing and Diagnostic Methods for Novel Cancer Biomarkers
Jagadeeswara Rao Bommi, Shekher Kummari, Kavitha Lakavath, et al.
Biosensors (2023) Vol. 13, Iss. 3, pp. 398-398
Open Access | Times Cited: 30
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Amphiphilic Polysaccharide Nanoballs: A New Building Block for Nanogel Biomedical Engineering and Artificial Chaperones
Haruko Takahashi, Shin‐ichi Sawada, Kazunari Akiyoshi
ACS Nano (2010) Vol. 5, Iss. 1, pp. 337-345
Closed Access | Times Cited: 92
Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives
Tao Zhang, Ruyi Yang, Shengnan Yang, et al.
Drug Delivery (2018) Vol. 25, Iss. 1, pp. 278-292
Open Access | Times Cited: 68
A Hybrid Hydrogel Biomaterial by Nanogel Engineering: Bottom‐Up Design with Nanogel and Liposome Building Blocks to Develop a Multidrug Delivery System
Yurina Sekine, Yuki Moritani, Tomoko Ikeda‐Fukazawa, et al.
Advanced Healthcare Materials (2012) Vol. 1, Iss. 6, pp. 722-728
Open Access | Times Cited: 70
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine
Takuro Saito, Hisashi Wada, Makoto Yamasaki, et al.
Vaccine (2014) Vol. 32, Iss. 45, pp. 5901-5907
Closed Access | Times Cited: 64
Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6– and IL-8–Expressing Tumors through Predominant Induction of CXCR1 by IL-6
Shingo Eikawa, Yoshihiro Ohue, Kenta Kitaoka, et al.
The Journal of Immunology (2010) Vol. 185, Iss. 11, pp. 6734-6740
Open Access | Times Cited: 65
Translational nanoparticle engineering for cancer vaccines
Adam Grippin, Elias Sayour, Duane A. Mitchell
OncoImmunology (2017) Vol. 6, Iss. 10, pp. e1290036-e1290036
Open Access | Times Cited: 41
Recent advances and hurdles in melanoma immunotherapy
Camilla Jandus, Daniel E. Speiser, Pedro Romero
Pigment Cell & Melanoma Research (2009) Vol. 22, Iss. 6, pp. 711-723
Open Access | Times Cited: 46
Heteroclitic serological response in esophageal and prostate cancer patients after NY‐ESO‐1 protein vaccination
Junji Kawada, Hisashi Wada, Midori Isobe, et al.
International Journal of Cancer (2011) Vol. 130, Iss. 3, pp. 584-592
Open Access | Times Cited: 43
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
Mikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 4, pp. 663-675
Open Access | Times Cited: 31
Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination
Hisashi Wada, Eiichi Sato, Akiko Uenaka, et al.
International Journal of Cancer (2008) Vol. 123, Iss. 10, pp. 2362-2369
Open Access | Times Cited: 45
Nanogel-based antigen-delivery system for nasal vaccines
Yoshikazu Yuki, Tomonori Nochi, Il Gyu Kong, et al.
Biotechnology and Genetic Engineering Reviews (2013) Vol. 29, Iss. 1, pp. 61-72
Open Access | Times Cited: 34
Vaccines targeting the neovasculature of tumors
Agata Matejuk, Qixin Leng, Szu‐Ting Chou, et al.
Vascular Cell (2011) Vol. 3, Iss. 1, pp. 7-7
Open Access | Times Cited: 31
Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder
Bo Yin, Gang Liu, Xiaosong Wang, et al.
Urologic Oncology Seminars and Original Investigations (2011) Vol. 30, Iss. 6, pp. 886-892
Closed Access | Times Cited: 28
Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer
W. C. Watt, Denise L. Cecil, Mary L. Disis
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 245-253
Closed Access | Times Cited: 22
Lessons from Cancer Immunoediting in Cutaneous Melanoma
Mariana Aris, María Marcela Barrio, José Mordoh
Clinical and Developmental Immunology (2012) Vol. 2012, pp. 1-14
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top